Pages that link to "Q72126155"

The following pages link to Polymorphic thiopurine methyltransferase in erythrocytes is indicative of activity in leukemic blasts from children with acute lymphoblastic leukemia (Q72126155):

Displaying 40 items.

• Thiopurine S-methyltransferase deficiency: two nucleotide transitions define the most prevalent mutant allele associated with loss of catalytic activity in Caucasians (Q24676047) (← links)
• Species differences in tumour responses to cancer chemotherapy (Q28080727) (← links)
• Human thiopurine methyltransferase activity varies with red blood cell age (Q28365897) (← links)
• Assessment of Thiopurine-based drugs according to Thiopurine S-methyltransferase genotype in patients with Acute Lymphoblastic Leukemia (Q28612763) (← links)
• Pharmacogenomic studies of the anticancer and immunosuppressive thiopurines mercaptopurine and azathioprine (Q33380531) (← links)
• Therapeutic drug monitoring of antimetabolic cytotoxic drugs (Q33586713) (← links)
• Pharmacogenetics as a molecular basis for individualized drug therapy: the thiopurine S-methyltransferase paradigm (Q33600016) (← links)
• Pharmacogenetics: a tool for individualizing antineoplastic therapy (Q34099799) (← links)
• Thiopurine methyltransferase predicts the extent of cytotoxicty and DNA damage in astroglial cells after thioguanine exposure. (Q34117269) (← links)
• Pharmacogenetics of cancer therapy: getting personal (Q34386321) (← links)
• Pharmacokinetic considerations in the treatment of inflammatory bowel disease (Q34437920) (← links)
• Inherited NUDT15 variant is a genetic determinant of mercaptopurine intolerance in children with acute lymphoblastic leukemia (Q34459885) (← links)
• Acute lymphoblastic leukemia: optimizing treatment strategies in children (Q34661832) (← links)
• Pharmacogenomics: marshalling the human genome to individualise drug therapy (Q35090217) (← links)
• Chemotherapy individualization. (Q35188391) (← links)
• Optimizing immunomodulator therapy for inflammatory bowel disease (Q35577412) (← links)
• Clinical significance of azathioprine active metabolite concentrations in inflammatory bowel disease (Q35596702) (← links)
• Molecular pharmacodynamics in childhood leukemia (Q35619775) (← links)
• Thiopurine methyltransferase activity and its relationship to the occurrence of rejection episodes in paediatric renal transplant recipients treated with azathioprine (Q36053671) (← links)
• The thiopurines: an update (Q36305435) (← links)
• Pharmacogenetics and diseases of the colon (Q36404764) (← links)
• Clinical implication of thiopurine methyltransferase polymorphism in children with acute lymphoblastic leukemia: A preliminary Egyptian study (Q36458023) (← links)
• Pharmacogenetics of minimal residual disease response in children with B-precursor acute lymphoblastic leukemia: a report from the Children's Oncology Group (Q36491833) (← links)
• IMPDH activity in thiopurine-treated patients with inflammatory bowel disease - relation to TPMT activity and metabolite concentrations (Q36535994) (← links)
• Thiopurine treatment in inflammatory bowel disease: clinical pharmacology and implication of pharmacogenetically guided dosing (Q36747429) (← links)
• Thiopurine methyltransferase genotype-phenotype discordance and thiopurine active metabolite formation in childhood acute lymphoblastic leukaemia (Q36988021) (← links)
• Pharmacogenomic progress in individualized dosing of key drugs for cancer patients (Q37378994) (← links)
• Genome-wide discovery of loci influencing chemotherapy cytotoxicity (Q37416155) (← links)
• Implementation of TPMT testing (Q37678056) (← links)
• Genetic polymorphisms of NQO1, CYP1A1 and TPMT and susceptibility to acute lymphoblastic leukemia in a Tunisian population (Q39330661) (← links)
• Up-regulation of P-glycoprotein confers acquired resistance to 6-mercaptopurine in human chronic myeloid leukemia cells (Q39551249) (← links)
• A Physician's Guide to Azathioprine Metabolite Testing (Q40361187) (← links)
• Peripheral blood mononuclear cell DNA 6-thioguanine metabolite levels correlate with decreased interferon-gamma production in patients with Crohn's disease on AZA therapy (Q40528442) (← links)
• Pharmacokinetic optimisation of cancer chemotherapy. Effect on outcomes (Q41440111) (← links)
• Thiopurine S-methyltransferase as a target for drug interactions (Q42479765) (← links)
• Frequency of TPMT alleles in Indian patients with acute lymphatic leukemia and effect on the dose of 6-mercaptopurine (Q43261059) (← links)
• Genomewide Approach Validates Thiopurine Methyltransferase Activity Is a Monogenic Pharmacogenomic Trait. (Q46377291) (← links)
• Thiopurine methyltransferase activity in Spain: a study of 14,545 patients (Q50703486) (← links)
• The frequency and distribution of thiopurine S-methyltransferase alleles in south Iranian population. (Q54347571) (← links)
• Quantification of Thiopurine Nucleotides in Erythrocytes and Clinical Application to Pediatric Acute Lymphoblastic Leukemia. (Q64935179) (← links)